Suchergebnisse - "Hernando, Jorge"

PubPharm (49)

1

Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Hernando, J. | Roca-Herrera, M. | García-Álvarez, A. | +16

ErratumFor: Eur J Cancer. 2023 Jul;188:39-48. - PMID 37196483

2

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology : A Subgroup Analysis of the COSMIC-311 Study

enthalten in: Thyroid : official journal of the American Thyroid Association | 2024

von Capdevila, J. | Krajewska, J. | Hernando, J. | +13

3

DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype

enthalten in: Cell reports | 2023

von Cuesta-Borràs, E. | Salvans, C. | Arqués, O. | +16

4

Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Hernando, J. | Roca-Herrera, M. | García-Álvarez, A. | +16

ErratumIn: Eur J Cancer. 2024 Apr 11;:114061. - PMID 38609739

5

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations : data from the SEPTRALU study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21

6

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs : Results from the international HomeLAN survey

enthalten in: Journal of neuroendocrinology | 2023

von Hernando, J. | Kolarova, T. | Verslype, C. | +4

7

COVID-19 in patients with neuroendocrine neoplasms : 2-year results of the INTENSIVE study

enthalten in: Endocrine-related cancer | 2023

von Fazio, N. | Gervaso, L. | Halfdanarson, T. | +34

8

Impact of the COVID-19 pandemic in the early-onset colorectal cancer

enthalten in: Translational oncology | 2023

von Baraibar, I. | García, A. | Salvà, F. | +19

9

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin: the phase II DUNE trial (GETNE 1601)

enthalten in: ResearchSquare.com | 2023

von Capdevila, J. | Hernando, J. | Teule, A. | +20

10

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Mitjavila, M. | Jimenez-Fonseca, P. | Belló, P. | +21

1
2
3
4
5
Nächster »
[5]